IP Library › Granted Patent US 10,159,730
Granted Patent B2
US 10,159,730 · App. 14/913,152 · Granted Dec 25, 2018

Fowl adenovirus vaccine

Inventors: Michael Hess (Klosterneuburg, AT); Anna Schachner (Vienna, AT); Ana Marek (Vienna, AT); Barbara Jaskulska (Vienna, AT)
Assignee: VETERINÄRMEDIZINISCHE UNIVERSITÄT WIEN
A61K39/235A61K39/12C12N7/00G01N33/6854A61K2039/505A61K2039/545A61K2039/552A61K2039/55505A61K2039/55555A61K2039/55566A61K2039/55588C12N2710/10222C12N2710/10234G01N2333/075G01N2800/26G01N2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,159,730
App. No.
14/913,152
Granted
Dec 25, 2018
Kind
B2
Abstract

Disclosed is a vaccine comprising fiber (2) protein of Fowl Adeno-virus C (FAdV-C) or an immunogenic fragment thereof for use in preventing hepatitis-hydropericardium Syndrome (HHS) in birds, preferably in poultry, especially in broilers.

Claims (21)

1. A vaccine for use in preventing hepatitis-hydropericardium syndrome (HHS) in birds comprising fiber-2 protein of Fowl Adenovirus C (FAdV-C), wherein the vaccine is further defined as a subunit vaccine comprising an immuno-effective amount of an adjuvant.

2. The vaccine of claim 1 , wherein the adjuvant is Freund's complete adjuvant, Freund's incomplete adjuvant, aluminum hydroxide, Bordetella pertussis , saponin, muramyl dipeptide, ethylene vinyl acetate copolymer, oil, a vegetable oil or a mineral oil.

3. The vaccine of claim 2 , wherein the adjuvant is peanut oil or silicone oil.

4. The vaccine of claim 1 , wherein the fiber-2 protein of FAdV-C has a protein sequence of any one of SEQ ID NO: 9 through SEQ ID NO: 33.

5. The vaccine of claim 4 , wherein the sequence of the fiber-2 protein of FAdV-C is the protein sequence of SEQ ID NO: 23.

6. The vaccine of claim 1 , further comprising a pharmaceutically acceptable diluent and/or carrier.

7. The vaccine of claim 6 , wherein the pharmaceutically acceptable diluent and/or carrier comprises a water-for-injection, physiological saline, tissue culture medium, propylene glycol, polyethylene glycol, vegetable oil, or an injectable organic ester.

8. The vaccine of claim 1 , wherein the fiber-2 protein of FAdV-C is contained in an amount of 0.1 μg/ml to 10 mg/ml.

9. The vaccine of claim 8 , wherein the fiber-2 protein of FAdV-C is contained in an amount of 1 μg/ml to 1 mg/ml.

10. The vaccine of claim 9 , wherein the fiber-2 protein of FAdV-C is contained in an amount of 10 to 100 μg/ml.

11. The vaccine of claim 1 , consisting of:

fiber-2 protein of FAdV-C, in an amount of 0.1 μg to 10 mg; and

a pharmaceutically acceptable carrier and/or diluent and/or adjuvant.

12. The vaccine of claim 11 , wherein the fiber-2 protein of FAdV-C is in an amount of 1 μg to 1 mg.

13. The vaccine of claim 12 , wherein the fiber-2 protein of FAdV-C is in an amount of 10 to 100 μg.

14. A method for preventing HHS in birds, comprising administering to the birds a vaccine of claim 1 .

15. The method of claim 14 , wherein the birds are in a parent flock.

16. The method of claim 14 , wherein the birds are poultry.

17. The method of claim 16 , wherein the poultry are broilers.

18. A kit comprising an isolated fiber-2 protein of FAdV-C immobilized on a solid surface or an immunogenic fragment of a fiber-2 protein of FAdV-C immobilized on a solid surface.

19. The kit of claim 18 , further comprising a detection component that can detect the binding of an antibody to the immobilized fiber-2 protein of FAdV-C or the immobilized immunogenic fragment thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2016
From: HESS, MICHAEL; SCHACHNER, ANNA; MAREK, ANA; JASKULSKA, BARBARA
To: VETERINÄRMEDIZINISCHE UNIVERSITÄT WIEN
Reel/Frame 038813/0430 →
Priority Claims (1)
EP 13180849 · Aug 19, 2013 · regional
Continuity (1)
Related Publication 20160193323A1 · Jul 7, 2016